Pediatric Nephrology · 5 Nov 2026
Gene–metabolite–cardiac associations in the Chronic Kidney Disease in Children (CKiD) study
Arthur M. Leeh-index 13, Mark M. Mitsnefes, Craig S. Wong, Jennifer Roem, Michael E. March, Hakon Hakonarson, Rui Xiao, Joseph T. Flynn, Susan L. Furth, Bradley A. Warady, Ramachandran S. Vasan, Paul L. Kimmel, Aditya Surapaneni, Eugene P. Rhee, Pascal Schlosser, Morgan E. Grams, Michelle R. Denburg, On behalf of the CKiD Study Investigators
Citations by database
Each database indexes a different set of journals, preprints and books, so they are shown side by side rather than blended.
- OpenCitations0
- Crossref0
- Europe PMC0
Citations per year
The current year is still counting.
- 2026 so far0
Abstract
Abstract Background Characterizing gene–metabolite–cardiac associations in childhood chronic kidney disease (CKD) has the potential to identify new research directions or therapeutic targets for mitigating the excessive cardiovascular risk in childhood CKD. Methods The Chronic Kidney Disease in Children (CKiD) is a prospective cohort that recruited children with eGFR 30–90 ml/min/1.73 m 2 across 54 North American centers. Predictor and outcome variables included genotypes, metabolite levels, left ventricular mass index (LVMI) z-score, and left ventricular filling pressure (E/e’). Multivariable linear regression analyses assessed metabolite associations with either LVMI z-score or E/e’, adjusting for age, sex, CKD duration, glomerular etiology, renin-angiotensin-aldosterone-system blockade, hypertension, anemia, dyslipidemia, eGFR, and proteinuria. Significance was based on the Benjamini–Hochberg False Discovery Rate <0.05. Metabolites associated with cardiac markers were carried forward for a metabolite–genome-wide association study (mGWAS). Linear regression calculated the residual metabolite variability not explained by age, sex, and eGFR. Linear regression assessed metabolite residual variability versus genetic variant dosage at the Bonferroni-corrected genome-wide significance threshold (corrected for number of metabolites assessed). Results 556 unique participants with 574 metabolites and ~8.4 million SNPs were included. Sphingomyelin (d18:2/d18:1) and hypotaurine were associated with LVMI z-score. Isobutyrylglycine and 3beta-hydroxy-5-cholestenoate were associated with E/e’. Multiple genetic variants associated with these metabolites at p < 1.25E-8 ( p < [5E-8]/4, Bonferroni-corrected genome-wide significance threshold). Conclusions We identified metabolites associated with cardiac markers in children with CKD. We identified genetic associations with variability in these metabolites. Collectively, these gene–metabolite associations suggest roles for inflammation, increased oxidative stress, mitochondrial and energy dysmetabolism, and gut microbial dysbiosis in mediating cardiac pathology in childhood CKD.
What the data shows
- No database records a citation yet, as is usual for a paper this new.
- Arthur M. Lee has the highest h-index among the authors (13).
Graph
This paper in the middle, its authors and their most-cited papers below, the papers it cites to the left and the papers citing it to the right. The timeline lays every paper out by year.
Select a node for its details. Drag to pan, scroll to zoom, drag a node to move it.
Start with
Cited by 0 papers
Who cites this paper, from open citation data, with Crossref's record of each; the 100 newest when there are more.
References (49)
What it cites, from open citation data, with Crossref's record of each.
Sign in to see 29 more references
A free account opens the rest of the citing papers and references on every paper’s page.